Abstract: A control for a working apparatus having a boom arm. The apparatus includes a controller operable to receive signals from at least one pressure sensor. The at least one pressure sensor detects pressure of hydraulic fluid in at least one chamber of a control valve. The controller compares the signals from the at least one pressure sensor to parameters generated by testing the working apparatus. The controller predicts boom arm oscillations based on the comparison of the signals with the parameters, and generates a control signal in response to predicting the boom arm oscillations.

Abstract: The present invention relates to Streptomyces sp. producing tautomycetin which possesses an immunosuppressive or antibacterial activities, a process for preparing tautomycetin from the said microorganism, and an immunosuppressant or immunosuppressive pharmaceutical composition comprising tautomycetin as an active ingredient which suppresses interleukin-2 production, CD69 and interleukin-2 receptor(IL-2R) expression on the cell surface, and graft rejection in the organ transplantation. The present inventors isolated a soil microorganism which produces a substance possessing antibiotic and immunosuppressive activities, and identified the said microorganism and substance as a novel Streptomyces sp. and tautomycetin, respectively.

Abstract: A tailgate folding device for an automotive vehicle constructed to vertically fold a midsection of the tailgate and thereby to avoid an external lower end thereof from touching a ceiling when the tailgate is opened at a place where the ceiling is low, thus promoting an effective use of the tailgate even at a confined area. The device has a tailgate vertically foldable and dividable via a hinge point into an upper portion and a lower portion thereof, a manipulating unit mounted at a folded site of the tailgate to control folding of the tailgate, and a locking unit for adequately converting a relative rotation of the divided tailgate from a restricted state to a released state according to the operation of the manipulating unit.

Abstract: A tillage folding device of automotive vehicle constructed to vertically fold a midsection of the tailgate and thereby to avoid an external lower end thereof from touching a ceiling when the tailgate is opened at a place where the ceiling is low, promoting an effective use of tailgate even at a confined area, the device comprising: a tailgate vertically foldable and dividable via a hinge point into an upper portion and a lower portion thereof; a manipulating unit mounted at a folded site of the tailgate to control folding of the tailgate; and a locking unit for adequately converting a relative rotation of the divided tailgate from a restricted state to a released state according to operation of the manipulating unit.

Abstract: The present invention relates to Streptomyces sp. producing tautomycetin which possesses an immunosuppressive or antibacterial activities, a process for preparing tautomycetin from the said microorganism, and an immunosuppressant or immunosuppressive pharmaceutical composition comprising tautomycetin as an active ingredient which suppresses interleukin-2 production, CD69 and interleukin-2 receptor(IL-2R) expression on the cell surface, and graft rejection in the organ transplantation. The present inventors isolated a soil microorganism which produces a substance possessing antibiotic and immunosuppressive activities, and identified the said microorganism and substance as a novel Streptomyces sp. and tautomycetin, respectively.

Abstract: Compounds useful as angiogenesis inhibiting agents and processes for their preparation are disclosed. In one embodiment, the compounds of the invention are represented by Formula 1: ##STR1## Also disclosed is a pharmaceutical composition for inhibiting angiogenesis in a mammal, said composition comprising a compound of Formula 1, or a pharmaceutically acceptable salt thereof, as an active ingredient.

Abstract: Compounds useful as angiogenesis inhibiting agents and processes for their preparation are disclosed. In one embodiment, the compounds of the invention are represented by Formula 1: ##STR1## Also disclosed is a pharmaceutical composition for inhibiting angiogenesis in a mammal, said composition comprising a compound of Formula 1, or a pharmaceutically acceptable salt thereof, as an active ingredient.